Search images on Google Product Monograph
Active Ingredients:
- nivolumab, 240 MG/20 ML
- relatlimab, 80 MG/20 ML
DIN: 02541416
Dosage Form(s): SOLUTION
Route(s) of Administration: INTRAVENOUS
Description: SINGLE-USE VIAL
Schedule: Prescription
Company: BRISTOL-MYERS SQUIBB CANADA – official site
ATC:
- L01 - ANTINEOPLASTIC AGENTS (ATC, WHO, Wiki)
- L01F - (ATC, WHO)
- L01FY - (ATC, WHO)
- L01FY02 - NIVOLUMAB AND RELATLIMAB (WHO)
External Links for Opdualag:
Search on Google
- Opdualag side effects
- Opdualag dosage
- nivolumab side effects
- nivolumab dosage
- relatlimab side effects
- relatlimab dosage
Bristol-Myers Squibb Canada
Go to Bristol-Myers Squibb website to see drug product details. Sometimes you can find opdualag photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.